North Korea vs New Zealand: Statin use vs. average non-HDL cholesterol levels
North Korea
3.4
in 2018
New Zealand
3.4
in 2018
North Korea rank
75th
New Zealand rank
75th
Statin use vs. average non-HDL cholesterol levels over time
- North Korea
- New Zealand
How they compare
North Korea currently reports 3.4 against 3.4 in New Zealand, a difference of 0.
Across all 39 years both countries report, New Zealand has been ahead every year.
North Korea ranks 75th and New Zealand ranks 75th of 191 countries.
New Zealand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | North Korea | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.4 | 4.48 | 1.08 | New Zealand |
| 1990s | 3.4 | 4.31 | 0.91 | New Zealand |
| 2000s | 3.4 | 3.92 | 0.52 | New Zealand |
| 2010s | 3.4 | 3.53 | 0.1333 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, North Korea or New Zealand?
- North Korea, at 3.4 against 3.4 in New Zealand as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between North Korea and New Zealand?
- 0, with North Korea ahead.
- How many years of comparable data are there for North Korea and New Zealand?
- 39 years are reported by both, from 1980 to 2018.
- How do North Korea and New Zealand rank globally for statin use vs. average non-hdl cholesterol levels?
- North Korea ranks 75th and New Zealand ranks 75th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.